Shared Decision-Making in Lung Cancer Screening
Thomas Jefferson University and the American College of Chest Physicians have developed a unique online educational program titled, Shared Decision-Making in Lung Cancer Screening. The program includes three modules:
- Assessment of Eligibility for Lung Cancer Screening and Tobacco Treatment;
- Education About Lung Cancer Screening and Tobacco Treatment; and
- Support for Decision-Making About Lung Cancer Screening.
Learners who complete all three modules will be able to identify persons eligible for annual lung cancer screening, educate eligible persons about the potential benefits and harms of screening, help eligible persons make a well-informed, shared decision about screening, and inform persons who smoke or who have stopped smoking about available tobacco treatment services.
- Complete the online asynchronous sequential self-paced learning modules.
- Complete the online evaluation.
Program made possible in part by an independent educational grant from AstraZeneca Pharmaceuticals, an educational grant from Genentech, a member of the Roche Group, and an independent medical education grant from Merck, Sharp and Dohme Corp.
This course is designed specifically for primary care physicians and other healthcare providers, including NPs, PAs, and Respiratory Care workers.
After completing this online course, learners will be able to:
Module 1: Assessment of Eligibility for Lung Cancer Screening
- Identify eligibility criteria included in Centers for Medicare and Medicaid Services (CMS) and United States Preventive Services Task Force (USPSTF) recommendation.
- Practice calculating pack years of cigarette smoking history.
- Complete documentation with all necessary information in the chart, including eligibility for LCS and tobacco cessation, and referral for tobacco treatment.
Module 2: Education about Lung Cancer Screening
- Identify major lung cancer risk factors.
- Describe the use of low dose computed tomography (LDCT) to identify early lung cancers and the associated benefits and risks.
- Describe the importance of tobacco treatment for patients with current pack-year history.
- Identify information about low-or no-cost resources for tobacco treatment.
Module 3: Support for Decision Making about Lung Cancer Screening
- Compare the reasons patients may or may not choose to be screened.
- Identify steps in the shared decision-making process.
- Construct a screening action plan.
This educational activity is supported by a 4-year grant from the Bristol Myers Squibb Foundation.
This educational activity is jointly provided with the American College of Chest Physicians.
Lung Cancer Screening Shared-Decision Making Learning Program
Module 1: Assessment of Eligibility for Lung Cancer Screening and Tobacco Treatment
Module 2: Education about Lung Cancer Screening and Tobacco Treatment
Module 3: Shared Decision Making (SDM) about Lung Cancer Screening
This training program complements Jefferson’s centralized Lung Cancer Screening Program.
Jefferson Lung Cancer Screening Program
Jefferson Health has a centralized Lung Cancer Screening Program available at all Enterprise sites!
The Jefferson program will:
- Confirm eligibility for lung cancer screening.
- Educate patients through shared decision-making.
- Provide tobacco cessation counseling and initiate treatment.
- Coordinate low dose CT scan, including insurance authorization.
- Communicate screening results and recommendations in details with patients, PCPs, and specialists.
- Navigate fast track, multidisciplinary evaluation when indicated.
- Remind patients of exams for continued annual screening.
Place an order in EPIC or call (215) 955-LUNG
CONFLICT OF INTEREST
Thomas Jefferson University endorses the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.
All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity.
Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.
Exception: According to the Standards, it is not required to identify, mitigate, or disclose relevant financial relationships for any of the following activities:
- Accredited education that is non-clinical, such as leadership or communication skills training.
- Accredited education where the learner group is in control of content, such as a spontaneous case conversation among peers.
- Accredited self-directed education where the learner controls their educational goals and reports on changes that resulted, such as learning from teaching, remediation, or a personal development plan.
None of the planners have any conflict of interest to declare.
Ronald E. Myers, DSW, PhD-Activity Director
Amy Morris, MD
Rickie Brawer, PhD
Nneka Sederstrom, PhD
Melissa DiCarlo, MPH, MS
Prethi Selvan, MPH
Pamela Myers, MPH
Kristine Pham, MPH
None of the following course authors have any conflict of interest to declare.
Ronald E. Myers, DSW, PhD
Nichole Tanner, MD
Teresa Giamboy, CRNP
Nneka Sederstrom, PhD
Teresa Giamboy, DNP, CRNP, CCRN, CTTS-M
Rickie Brawer, PhD
Amy Morris, MD
The following course authors have the following relevant relationships to declare.
Robert J. Volk, DSW, PhD
- Grant/Research Support: American Cancer Society, Patient-Centered Outcomes Research Institute, National Institutes of Health, Cancer Prevention Research Institute, Susan G. Komen Foundation
Jamie Studts, PhD
- Uncompensated Presenter: Genentech
- Consultant: Johnson and Johnson
- Scientific Advisor: Lung Ambition Alliance
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, this activity has been planned and implemented by Thomas Jefferson University and American College of Chest Physicians. Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: This educational activity is designated for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 1.25 nursing contact hours.
Other Healthcare Professionals: This educational activity is designated for 1.25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Issue Date: May 17, 2021
Expiration Date: May 16, 2023
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Attendance
- 1.25 CNE
This online course requires a stable internet connection and a mechanism for audio.